Abstract:Novel, non-invasive biomarkers to diagnose breast cancer with high sensitivity and specificity are greatly desired. Circulating microRNAs (miRNAs) show potential for breast cancer detection, but the existing results appear to be mixed. Using microscale serum, we established a novel serum-direct multiplex detection assay based on RT-PCR (SdM-RT-PCR). Ninety-three miRNAs dysregulated or with functions in breast cancer were selected as candidates, and additional 3 miRNAs were chosen as endogenous controls. We first conducted miRNA profiling of these 96 miRNAs by SdM-RT-PCR using the sera of 25 breast cancer patients at diagnosis prior to treatment and 20 age-matched healthy controls. miRNAs showing significantly different expression levels between patients and controls were further analyzed using a logistic regression model. A miRNA signature was validated in an independent set of 128 serum samples composed of 76 breast cancer patients and 52 healthy controls. In the discovery stage, we identified 23 miRNAs as significantly dysregulated in breast cancer patients compared with healthy controls. Of these, 10 miRNAs were previously identified as dysregulated in breast cancer; 14 miRNAs remained significant after P -values were adjusted by both correction methods. Principal component analysis and hierarchical clustering of these miRNAs separated patients from controls. Furthermore, the 3-miRNA signature (miR-199a, miR-29c, and miR-424) with the highest diagnostic accuracy for distinguishing breast cancer patients from controls by ROC curve analysis (AUC = 0.888) was successfully confirmed in the validation set (AUC = 0.901). Our data demonstrate that the SdM-RT-PCR assay is an effective breast cancer profiling method that utilizes very small volumes and is compatible with Biobank. Furthermore, the identified 3-miRNA signature is a promising circulating biomarker for breast cancer diagnosis.

Identification of Circulating Mirna Biomarkers Based on Global Quantitative Real-Time PCR Profiling

A universal linker-RT PCR based quantitative method for the detection of circulating miRNAs

Establishment of Plasma Microrna Detection Method by Using Taqman Probe Based Quantitative Reverse Transcription Pcr

An Ultrasensitive and Multiplexed Mirna One-Step Real Time RT-qPCR Detection System and Its Application in Esophageal Cancer Serum

Real-Time Polymerase Chain Reaction MicroRNA Detection Based on Enzymatic Stem-Loop Probes Ligation

Analysis of Plasma Mir-208A and Mir-370 Expression Levels for Early Diagnosis of Coronary Artery Disease

Characterization of Circulating Microrna and Its Clinical Application

Semiarbitrary qPCR for Sensitive Detection of Circulating miRNA via Terminal Deoxynucleotidyl Transferase-Assisted RNA-Primed DNA Polymerization

Circulating microRNAs: Biomarkers of disease

A Direct Quantification Method for Measuring Plasma MicroRNAs Identified Potential Biomarkers for Detecting Metastatic Breast Cancer.

Extraction-Free Absolute Quantification of Circulating miRNAs by Chip-Based Digital PCR

Multiplexed and Accurate Quantification Strategy for Mirna Based on Specific Terminal-Mediated PCR with Equivalent Amplification

Circulating Plasma Mirnas As Potential Biomarkers of Non-Small Cell Lung Cancer Obtained by High-Throughput Real-Time PCR Profiling

A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer

A Simplified And Optimal Rt-Qpcr Strategy For Extracellular Mirna Profiling

Circulating microRNAs as Promising Tumor Biomarkers.

Mirna Quantification Methods Basing on PCR Technique

Considerations and Suggestions for the Reliable Analysis of miRNA in Plasma Using qRT-PCR

Development and Application of a Novel Reverse Transcription Real-Time PCR Method for Mir-499 Quantification

Digital quantification of miRNA directly in plasma using integrated comprehensive droplet digital detection

Serum And Plasma Mirna Detection